ELITE PHARMACEUTICALS INC /NV/

Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and manufactures generic pharmaceuticals and oral, controlled-release medications. Its product portfolio spans several therapeutic classes, including central nervous system stimulants, pain management treatments, bariatric medications, cardiovascular agents, muscle relaxants, antidepressants, and antimetabolites. The company's commercial offerings include generic formulations such as amphetamine tablets and capsules, lisdexamfetamine, phentermine, naltrexone, and opioid combination pain relievers. Elite operates primarily through manufacturing and product licensing activities. The company sells its pharmaceutical products directly and indirectly to wholesale distributors, and it also collaborates with commercial partners through licensing agreements.

The company conducts its operations across three facilities located on Ludlow Avenue in Northvale, New Jersey, which house manufacturing, warehouse, laboratory, and administrative space. These facilities operate under Current Good Manufacturing Practice guidelines and hold Drug Enforcement Administration registrations. Elite distributes products in the United States and supplies medications for the Israeli market through an international distribution partner. Elite Pharmaceuticals is headquartered in Northvale, New Jersey.

Summary of the business section of Elite Pharmaceuticals's latest annual report, written by StockData.

“of June 25, 2026, we had 65 full-time employees.”